Insights - BIO

Areas of Work

	Biotechnology Industry Posts 37 FDA Approvals, $16.4 Billion in Financing in 2003 Jan 5 2004 WASHINGTON, D.C. (January 5, 2004) — The biotechnology industry enters 2004 stronger than ever after earning 37 FDA approvals, raising $16.4 billion in new financing and winning significant battles...
	BIO Statement on European Pharmaceutical Legislation Requiring Testing for 'Biosimilar' Products Dec 18 2003 WASHINGTON, D.C. (December 18, 2003) — Biotechnology Industry Organization (BIO) President Carl B. Feldbaum issued the following statement in response to a vote by the European Union (EU)...
	Media Registration Now Available Online For BIO CEO & Investor Conference 2004 Dec 11 2003 WASHINGTON, D.C. (December 11, 2003) - Advance media registration is now open for the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2004, scheduled February 23-25 at the...
	Medicare Drug Coverage Will Expand Access to Biotech Products Nov 25 2003 Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement regarding congressional passage of the Medicare Prescription Drug and Modernization Act of 2003.
	BIO Urges Swift Passage of Medicare Agreement Nov 17 2003 WASHINGTON, D.C. (November 17, 2003)— Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in response to the House-Senate conference...
	Stock Option Expensing Will Harm Small Biotech Companies Nov 12 2003 WASHINGTON, D.C. (November 12, 2003) — During testimony today before the Senate Subcommittee on Securities and Investment, Walter K. Moore, vice president for government affairs at Genentech Inc.,...
	Commerce Department to Release Biotech Survey Nov 10 2003 WASHINGTON, D.C. (November 10, 2003) -- The U.S. Commerce Department will release a new report, A Survey of the Use of Biotechnology in U.S. Industry, at a press conference on Thursday,...
	Pharmacogenomics Draft Guidance A Significant Step Toward Personalized Medicine Nov 3 2003 Washington, D.C. (November 3, 2003) – Gillian Woollett, the Biotechnology Industry Organization's vice president for science and regulatory affairs, issued the following statement in response...
	BIO Statement: FDA Risk Assessment Finds Food Products from Cloned Animals Safe Oct 31 2003 WASHINGTON (October 31, 2003) – Lisa Dry, communications director of the Biotechnology Industry Organization (BIO), issued the following statement in response to a risk assessment provided...
	Commerce Department Issues First Comprehensive Report on Use of Biotechnology in U.S. Industry Oct 27 2003 The Department of Commerce's Office of Technology Policy/Technology Administration (OTP/TA) and the Office of Strategic Industries and Economic Security, Bureau of Industry and Security (OSIES/BIS)...